JP2007516209A - 脱毛症の予防および治療的処置用組成物の製造のためのペプチド複合体の使用 - Google Patents
脱毛症の予防および治療的処置用組成物の製造のためのペプチド複合体の使用 Download PDFInfo
- Publication number
- JP2007516209A JP2007516209A JP2006519970A JP2006519970A JP2007516209A JP 2007516209 A JP2007516209 A JP 2007516209A JP 2006519970 A JP2006519970 A JP 2006519970A JP 2006519970 A JP2006519970 A JP 2006519970A JP 2007516209 A JP2007516209 A JP 2007516209A
- Authority
- JP
- Japan
- Prior art keywords
- lys
- acid
- gly
- peptide
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 18
- 201000004384 Alopecia Diseases 0.000 title claims description 16
- 231100000360 alopecia Toxicity 0.000 title claims description 11
- 230000002265 prevention Effects 0.000 title claims description 6
- 230000001225 therapeutic effect Effects 0.000 title claims description 5
- 238000004519 manufacturing process Methods 0.000 title abstract description 3
- 239000000863 peptide conjugate Substances 0.000 title description 10
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 55
- 239000002537 cosmetic Substances 0.000 claims abstract description 13
- 239000002253 acid Substances 0.000 claims description 16
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 12
- 150000001875 compounds Chemical class 0.000 claims description 10
- 210000004209 hair Anatomy 0.000 claims description 10
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 claims description 6
- 229960004502 levodopa Drugs 0.000 claims description 6
- 210000004761 scalp Anatomy 0.000 claims description 6
- RRJOMESUBQAYOA-BZSNNMDCSA-N (2S)-2-[[(2S)-2-[[2-[[(2S)-2-acetamido-6-aminohexanoyl]amino]acetyl]amino]-3-(1H-imidazol-5-yl)propanoyl]amino]-6-aminohexanamide Chemical compound NCCCC[C@H](NC(=O)C)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(N)=O)CC1=CN=CN1 RRJOMESUBQAYOA-BZSNNMDCSA-N 0.000 claims description 5
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 claims description 5
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 claims description 5
- 235000020660 omega-3 fatty acid Nutrition 0.000 claims description 5
- 229930002330 retinoic acid Natural products 0.000 claims description 5
- 229960002663 thioctic acid Drugs 0.000 claims description 5
- 229960001727 tretinoin Drugs 0.000 claims description 5
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 claims description 4
- -1 N-lipoyl-lysine Chemical compound 0.000 claims description 4
- 150000007513 acids Chemical class 0.000 claims description 4
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims description 4
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 claims description 4
- 239000003795 chemical substances by application Substances 0.000 claims description 4
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 4
- 230000000306 recurrent effect Effects 0.000 claims description 4
- 238000012216 screening Methods 0.000 claims description 4
- OIQXFRANQVWXJF-QBFSEMIESA-N (2z)-2-benzylidene-4,7,7-trimethylbicyclo[2.2.1]heptan-3-one Chemical class CC1(C)C2CCC1(C)C(=O)\C2=C/C1=CC=CC=C1 OIQXFRANQVWXJF-QBFSEMIESA-N 0.000 claims description 3
- HXQHFNIKBKZGRP-URPRIDOGSA-N (5Z,9Z,12Z)-octadecatrienoic acid Chemical compound CCCCC\C=C/C\C=C/CC\C=C/CCCC(O)=O HXQHFNIKBKZGRP-URPRIDOGSA-N 0.000 claims description 3
- HXQHFNIKBKZGRP-UHFFFAOYSA-N Ranuncelin-saeure-methylester Natural products CCCCCC=CCC=CCCC=CCCCC(O)=O HXQHFNIKBKZGRP-UHFFFAOYSA-N 0.000 claims description 3
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 3
- 125000001931 aliphatic group Chemical group 0.000 claims description 3
- 150000001413 amino acids Chemical class 0.000 claims description 3
- 235000015872 dietary supplement Nutrition 0.000 claims description 3
- 235000020669 docosahexaenoic acid Nutrition 0.000 claims description 3
- 150000002148 esters Chemical class 0.000 claims description 3
- AGBQKNBQESQNJD-UHFFFAOYSA-N lipoic acid Chemical compound OC(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-N 0.000 claims description 3
- 235000019136 lipoic acid Nutrition 0.000 claims description 3
- 229960003632 minoxidil Drugs 0.000 claims description 3
- 230000000699 topical effect Effects 0.000 claims description 3
- 239000011701 zinc Substances 0.000 claims description 3
- 229910052725 zinc Inorganic materials 0.000 claims description 3
- HEOCBCNFKCOKBX-RELGSGGGSA-N (1s,2e,4r)-4,7,7-trimethyl-2-[(4-methylphenyl)methylidene]bicyclo[2.2.1]heptan-3-one Chemical compound C1=CC(C)=CC=C1\C=C/1C(=O)[C@]2(C)CC[C@H]\1C2(C)C HEOCBCNFKCOKBX-RELGSGGGSA-N 0.000 claims description 2
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 claims description 2
- IZFHEQBZOYJLPK-SSDOTTSWSA-N (R)-dihydrolipoic acid Chemical compound OC(=O)CCCC[C@@H](S)CCS IZFHEQBZOYJLPK-SSDOTTSWSA-N 0.000 claims description 2
- QLAJNZSPVITUCQ-UHFFFAOYSA-N 1,3,2-dioxathietane 2,2-dioxide Chemical compound O=S1(=O)OCO1 QLAJNZSPVITUCQ-UHFFFAOYSA-N 0.000 claims description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims description 2
- JGUMTYWKIBJSTN-UHFFFAOYSA-N 2-ethylhexyl 4-[[4,6-bis[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 JGUMTYWKIBJSTN-UHFFFAOYSA-N 0.000 claims description 2
- QSTURKXDYNIRGT-UHFFFAOYSA-N 2-hydroxydec-2-enoic acid Chemical compound CCCCCCCC=C(O)C(O)=O QSTURKXDYNIRGT-UHFFFAOYSA-N 0.000 claims description 2
- ORWUQAQITKSSRZ-UHFFFAOYSA-N 2-hydroxyethyl 4-[bis[2-(2-hydroxyethoxy)ethyl]amino]benzoate Chemical compound OCCOCCN(CCOCCO)C1=CC=C(C(=O)OCCO)C=C1 ORWUQAQITKSSRZ-UHFFFAOYSA-N 0.000 claims description 2
- WXBXVVIUZANZAU-UHFFFAOYSA-N 2E-decenoic acid Natural products CCCCCCCC=CC(O)=O WXBXVVIUZANZAU-UHFFFAOYSA-N 0.000 claims description 2
- 239000002677 5-alpha reductase inhibitor Substances 0.000 claims description 2
- JQFZHHSQMKZLRU-IUCAKERBSA-N Arg-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](N)CCCN=C(N)N JQFZHHSQMKZLRU-IUCAKERBSA-N 0.000 claims description 2
- MJINRRBEMOLJAK-DCAQKATOSA-N Arg-Lys-Asp Chemical compound OC(=O)C[C@@H](C(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCN=C(N)N MJINRRBEMOLJAK-DCAQKATOSA-N 0.000 claims description 2
- 241000723346 Cinnamomum camphora Species 0.000 claims description 2
- GFLQTABMFBXRIY-GUBZILKMSA-N Glu-Gln-Arg Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O GFLQTABMFBXRIY-GUBZILKMSA-N 0.000 claims description 2
- XLFHCWHXKSFVIB-BQBZGAKWSA-N Gly-Gln-Gln Chemical group NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O XLFHCWHXKSFVIB-BQBZGAKWSA-N 0.000 claims description 2
- ZFMITUMMTDLWHR-UHFFFAOYSA-N Minoxidil Chemical compound NC1=[N+]([O-])C(N)=CC(N2CCCCC2)=N1 ZFMITUMMTDLWHR-UHFFFAOYSA-N 0.000 claims description 2
- WYWZRNAHINYAEF-UHFFFAOYSA-N Padimate O Chemical compound CCCCC(CC)COC(=O)C1=CC=C(N(C)C)C=C1 WYWZRNAHINYAEF-UHFFFAOYSA-N 0.000 claims description 2
- 235000021314 Palmitic acid Nutrition 0.000 claims description 2
- 108010003201 RGH 0205 Proteins 0.000 claims description 2
- 235000011054 acetic acid Nutrition 0.000 claims description 2
- 235000020661 alpha-linolenic acid Nutrition 0.000 claims description 2
- 229960004050 aminobenzoic acid Drugs 0.000 claims description 2
- 229940121363 anti-inflammatory agent Drugs 0.000 claims description 2
- 239000002260 anti-inflammatory agent Substances 0.000 claims description 2
- 108010062796 arginyllysine Proteins 0.000 claims description 2
- 229960001716 benzalkonium Drugs 0.000 claims description 2
- CYDRXTMLKJDRQH-UHFFFAOYSA-N benzododecinium Chemical compound CCCCCCCCCCCC[N+](C)(C)CC1=CC=CC=C1 CYDRXTMLKJDRQH-UHFFFAOYSA-N 0.000 claims description 2
- 229960000846 camphor Drugs 0.000 claims description 2
- 229930008380 camphor Natural products 0.000 claims description 2
- 229940090949 docosahexaenoic acid Drugs 0.000 claims description 2
- 229960004697 enzacamene Drugs 0.000 claims description 2
- 229960004881 homosalate Drugs 0.000 claims description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 2
- 229960004488 linolenic acid Drugs 0.000 claims description 2
- 125000003588 lysine group Chemical group [H]N([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 claims description 2
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 claims description 2
- 229960000601 octocrylene Drugs 0.000 claims description 2
- 229920002401 polyacrylamide Polymers 0.000 claims description 2
- 229960003471 retinol Drugs 0.000 claims description 2
- 235000020944 retinol Nutrition 0.000 claims description 2
- 239000011607 retinol Substances 0.000 claims description 2
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 claims description 2
- WXBXVVIUZANZAU-CMDGGOBGSA-N trans-2-decenoic acid Chemical compound CCCCCCC\C=C\C(O)=O WXBXVVIUZANZAU-CMDGGOBGSA-N 0.000 claims description 2
- JFOWDKWFHZIMTR-RUCXOUQFSA-N (2s)-2-aminopentanedioic acid;(2s)-2,5-diamino-5-oxopentanoic acid Chemical compound OC(=O)[C@@H](N)CCC(N)=O.OC(=O)[C@@H](N)CCC(O)=O JFOWDKWFHZIMTR-RUCXOUQFSA-N 0.000 claims 1
- HYZJCKYKOHLVJF-UHFFFAOYSA-N 1H-benzimidazole Chemical compound C1=CC=C2NC=NC2=C1 HYZJCKYKOHLVJF-UHFFFAOYSA-N 0.000 claims 1
- LSHGMOIQPURPAK-UHFFFAOYSA-N 2-benzylidene-1,4,7,7-tetramethylbicyclo[2.2.1]heptan-3-one Chemical compound CC1(C)C(C2=O)(C)CCC1(C)C2=CC1=CC=CC=C1 LSHGMOIQPURPAK-UHFFFAOYSA-N 0.000 claims 1
- WSSJONWNBBTCMG-UHFFFAOYSA-N 2-hydroxybenzoic acid (3,3,5-trimethylcyclohexyl) ester Chemical compound C1C(C)(C)CC(C)CC1OC(=O)C1=CC=CC=C1O WSSJONWNBBTCMG-UHFFFAOYSA-N 0.000 claims 1
- CNXZMGRWEYQCOQ-UHFFFAOYSA-N 2-methoxy-3-phenylprop-2-enoic acid Chemical compound COC(C(O)=O)=CC1=CC=CC=C1 CNXZMGRWEYQCOQ-UHFFFAOYSA-N 0.000 claims 1
- 229940113178 5 Alpha reductase inhibitor Drugs 0.000 claims 1
- FMRHJJZUHUTGKE-UHFFFAOYSA-N Ethylhexyl salicylate Chemical compound CCCCC(CC)COC(=O)C1=CC=CC=C1O FMRHJJZUHUTGKE-UHFFFAOYSA-N 0.000 claims 1
- UBNYRXMKIIGMKK-RMKNXTFCSA-N amiloxate Chemical compound COC1=CC=C(\C=C\C(=O)OCCC(C)C)C=C1 UBNYRXMKIIGMKK-RMKNXTFCSA-N 0.000 claims 1
- 229940114081 cinnamate Drugs 0.000 claims 1
- UVCJGUGAGLDPAA-UHFFFAOYSA-N ensulizole Chemical compound N1C2=CC(S(=O)(=O)O)=CC=C2N=C1C1=CC=CC=C1 UVCJGUGAGLDPAA-UHFFFAOYSA-N 0.000 claims 1
- 229960000655 ensulizole Drugs 0.000 claims 1
- 229940068171 ethyl hexyl salicylate Drugs 0.000 claims 1
- 229960003512 nicotinic acid Drugs 0.000 claims 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N nicotinic acid Natural products OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims 1
- 235000001968 nicotinic acid Nutrition 0.000 claims 1
- 239000011664 nicotinic acid Substances 0.000 claims 1
- FMJSMJQBSVNSBF-UHFFFAOYSA-N octocrylene Chemical group C=1C=CC=CC=1C(=C(C#N)C(=O)OCC(CC)CCCC)C1=CC=CC=C1 FMJSMJQBSVNSBF-UHFFFAOYSA-N 0.000 claims 1
- 150000003902 salicylic acid esters Chemical class 0.000 claims 1
- WBYWAXJHAXSJNI-VOTSOKGWSA-M trans-cinnamate Chemical compound [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 claims 1
- 150000003918 triazines Chemical class 0.000 claims 1
- 230000003779 hair growth Effects 0.000 abstract description 8
- 230000004936 stimulating effect Effects 0.000 abstract description 4
- MVORZMQFXBLMHM-QWRGUYRKSA-N Gly-His-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)CN)CC1=CN=CN1 MVORZMQFXBLMHM-QWRGUYRKSA-N 0.000 abstract description 2
- 108010038983 glycyl-histidyl-lysine Proteins 0.000 abstract description 2
- 230000003658 preventing hair loss Effects 0.000 abstract 1
- 210000003780 hair follicle Anatomy 0.000 description 12
- 102000004196 processed proteins & peptides Human genes 0.000 description 12
- 210000004027 cell Anatomy 0.000 description 7
- 230000000694 effects Effects 0.000 description 5
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 4
- 230000003698 anagen phase Effects 0.000 description 4
- 230000003676 hair loss Effects 0.000 description 4
- 208000024963 hair loss Diseases 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 3
- 150000001408 amides Chemical class 0.000 description 3
- 230000002500 effect on skin Effects 0.000 description 3
- 238000000338 in vitro Methods 0.000 description 3
- 239000006210 lotion Substances 0.000 description 3
- 239000011159 matrix material Substances 0.000 description 3
- OSCJHTSDLYVCQC-UHFFFAOYSA-N 2-ethylhexyl 4-[[4-[4-(tert-butylcarbamoyl)anilino]-6-[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)NC(C)(C)C)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 OSCJHTSDLYVCQC-UHFFFAOYSA-N 0.000 description 2
- 108010066551 Cholestenone 5 alpha-Reductase Proteins 0.000 description 2
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 2
- HXWJFEZDFPRLBG-UHFFFAOYSA-N Timnodonic acid Natural products CCCC=CC=CCC=CCC=CCC=CCCCC(O)=O HXWJFEZDFPRLBG-UHFFFAOYSA-N 0.000 description 2
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 2
- 230000003778 catagen phase Effects 0.000 description 2
- 235000020673 eicosapentaenoic acid Nutrition 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 210000004919 hair shaft Anatomy 0.000 description 2
- 230000002045 lasting effect Effects 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 229960003604 testosterone Drugs 0.000 description 2
- SBHCLVQMTBWHCD-METXMMQOSA-N (2e,4e,6e,8e,10e)-icosa-2,4,6,8,10-pentaenoic acid Chemical compound CCCCCCCCC\C=C\C=C\C=C\C=C\C=C\C(O)=O SBHCLVQMTBWHCD-METXMMQOSA-N 0.000 description 1
- CSYHYMSAUJTNIR-UHFFFAOYSA-N C(C1=CC=CC=C1)=C1C(C2(CCC1C2(C)C)C)=O.C2(=CC=CC=C2)C2=CC=CC=1N=C(NC12)S(=O)(=O)O Chemical class C(C1=CC=CC=C1)=C1C(C2(CCC1C2(C)C)C)=O.C2(=CC=CC=C2)C2=CC=CC=1N=C(NC12)S(=O)(=O)O CSYHYMSAUJTNIR-UHFFFAOYSA-N 0.000 description 1
- KTSZUNRRYXPZTK-BQBZGAKWSA-N Gly-Gln-Glu Chemical compound NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O KTSZUNRRYXPZTK-BQBZGAKWSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- WTDRDQBEARUVNC-LURJTMIESA-N L-DOPA Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-LURJTMIESA-N 0.000 description 1
- WTDRDQBEARUVNC-UHFFFAOYSA-N L-Dopa Natural products OC(=O)C(N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-UHFFFAOYSA-N 0.000 description 1
- JTTHKOPSMAVJFE-VIFPVBQESA-N L-homophenylalanine Chemical compound OC(=O)[C@@H](N)CCC1=CC=CC=C1 JTTHKOPSMAVJFE-VIFPVBQESA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- OLYPWXRMOFUVGH-LURJTMIESA-N N(2)-methyl-L-lysine Chemical compound CN[C@H](C(O)=O)CCCCN OLYPWXRMOFUVGH-LURJTMIESA-N 0.000 description 1
- PQNASZJZHFPQLE-LURJTMIESA-N N(6)-methyl-L-lysine Chemical compound CNCCCC[C@H](N)C(O)=O PQNASZJZHFPQLE-LURJTMIESA-N 0.000 description 1
- HJCLGNPWNFCRSB-UHFFFAOYSA-N N1=CNC2=C1C=CC=C2.C(C=2C(O)=CC=CC2)(=O)OC(CCCCC)CC Chemical class N1=CNC2=C1C=CC=C2.C(C=2C(O)=CC=CC2)(=O)OC(CCCCC)CC HJCLGNPWNFCRSB-UHFFFAOYSA-N 0.000 description 1
- MREBZTXYTWMTOG-UHFFFAOYSA-N N1=NN=CC=C1.CC12C(C(C(CC1)(C2(C)C)C)=O)=CC2=CC=CC=C2 Chemical class N1=NN=CC=C1.CC12C(C(C(CC1)(C2(C)C)C)=O)=CC2=CC=CC=C2 MREBZTXYTWMTOG-UHFFFAOYSA-N 0.000 description 1
- 101800005164 Peptide V Proteins 0.000 description 1
- 108010077895 Sarcosine Proteins 0.000 description 1
- 206010040954 Skin wrinkling Diseases 0.000 description 1
- 208000002847 Surgical Wound Diseases 0.000 description 1
- 206010044565 Tremor Diseases 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 description 1
- 206010068168 androgenetic alopecia Diseases 0.000 description 1
- 201000002996 androgenic alopecia Diseases 0.000 description 1
- 230000003656 anti-hair-loss Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- IAQRGUVFOMOMEM-UHFFFAOYSA-N butene Natural products CC=CC IAQRGUVFOMOMEM-UHFFFAOYSA-N 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000007248 cellular mechanism Effects 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- MHUWZNTUIIFHAS-CLFAGFIQSA-N dioleoyl phosphatidic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(COP(O)(O)=O)OC(=O)CCCCCCC\C=C/CCCCCCCC MHUWZNTUIIFHAS-CLFAGFIQSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- MBMBGCFOFBJSGT-UHFFFAOYSA-N docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CCC=CCC=CCC=CCC=CCC=CCC=CCCC(O)=O MBMBGCFOFBJSGT-UHFFFAOYSA-N 0.000 description 1
- 229960005135 eicosapentaenoic acid Drugs 0.000 description 1
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 description 1
- DBEPLOCGEIEOCV-WSBQPABSSA-N finasteride Chemical compound N([C@@H]1CC2)C(=O)C=C[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H](C(=O)NC(C)(C)C)[C@@]2(C)CC1 DBEPLOCGEIEOCV-WSBQPABSSA-N 0.000 description 1
- 229960004039 finasteride Drugs 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000016507 interphase Effects 0.000 description 1
- 229940103903 medicated shampoo Drugs 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 230000011987 methylation Effects 0.000 description 1
- 238000007069 methylation reaction Methods 0.000 description 1
- 230000009456 molecular mechanism Effects 0.000 description 1
- 150000002762 monocarboxylic acid derivatives Chemical class 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000003711 photoprotective effect Effects 0.000 description 1
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 1
- DNIAPMSPPWPWGF-UHFFFAOYSA-N propylene glycol Substances CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 1
- 230000000284 resting effect Effects 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical compound C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 210000000130 stem cell Anatomy 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000003797 telogen phase Effects 0.000 description 1
- 238000011200 topical administration Methods 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q7/00—Preparations for affecting hair growth
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/07—Tetrapeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/57—Compounds covalently linked to a(n inert) carrier molecule, e.g. conjugates, pro-fragrances
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Dermatology (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Birds (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cosmetics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0308801A FR2857597B1 (fr) | 2003-07-18 | 2003-07-18 | Utilisation de conjugues peptidiques pour la preparation de compositions destinees au traitement preventif et curatif de l'alopecie. |
| PCT/FR2004/001879 WO2005009456A2 (fr) | 2003-07-18 | 2004-07-16 | Utilisation de conjugues peptidiques pour la preparation de compositions destinees au traitement preventif et curatif de l’alopecie |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012178403A Division JP6006582B2 (ja) | 2003-07-18 | 2012-08-10 | 脱毛症の予防および治療的処置用組成物の製造のためのペプチド複合体の使用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007516209A true JP2007516209A (ja) | 2007-06-21 |
| JP2007516209A5 JP2007516209A5 (enExample) | 2010-01-14 |
Family
ID=33548254
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006519970A Pending JP2007516209A (ja) | 2003-07-18 | 2004-07-16 | 脱毛症の予防および治療的処置用組成物の製造のためのペプチド複合体の使用 |
| JP2012178403A Expired - Lifetime JP6006582B2 (ja) | 2003-07-18 | 2012-08-10 | 脱毛症の予防および治療的処置用組成物の製造のためのペプチド複合体の使用 |
| JP2015022587A Expired - Lifetime JP6149053B2 (ja) | 2003-07-18 | 2015-02-06 | 脱毛症の予防および治療的処置用組成物の製造のためのペプチド複合体の使用 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012178403A Expired - Lifetime JP6006582B2 (ja) | 2003-07-18 | 2012-08-10 | 脱毛症の予防および治療的処置用組成物の製造のためのペプチド複合体の使用 |
| JP2015022587A Expired - Lifetime JP6149053B2 (ja) | 2003-07-18 | 2015-02-06 | 脱毛症の予防および治療的処置用組成物の製造のためのペプチド複合体の使用 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US7507719B2 (enExample) |
| EP (1) | EP1663285B1 (enExample) |
| JP (3) | JP2007516209A (enExample) |
| CA (1) | CA2532679C (enExample) |
| ES (1) | ES2401686T3 (enExample) |
| FR (1) | FR2857597B1 (enExample) |
| WO (1) | WO2005009456A2 (enExample) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2010531815A (ja) * | 2007-06-29 | 2010-09-30 | イノーバクティブ インク． | 新規化合物、化粧品用途および薬用化粧品用途におけるその使用、および該化合物を含む組成物 |
| JP2018532774A (ja) * | 2015-10-09 | 2018-11-08 | アンスティテュ・ヨーロペアン・ドゥ・ビョロジ・セリュレールＩｎｓｔｉｔｕｔ Ｅｕｒｏｐｅｅｎ Ｄｅ Ｂｉｏｌｏｇｉｅ Ｃｅｌｌｕｌａｉｒｅ | 脱毛症の予防的及び根治的治療において使用するペプチド |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20100310484A1 (en) * | 2007-06-29 | 2010-12-09 | Innovactiv Inc. | Novel peptides, use thereof in cosmetic and cosmeceutic applications, and compositions comprising same |
| PT2165698E (pt) | 2008-09-18 | 2016-06-23 | Universkin | Composição cosmética para cuidar a pele agredida |
| WO2014120793A1 (en) * | 2013-01-30 | 2014-08-07 | The Beauty Cartel, Llc. | Hair loss treatment compositions and methods of making and using same |
| KR101578901B1 (ko) * | 2013-09-11 | 2015-12-28 | (주)셀아이콘랩 | 발모 촉진 펩타이드, 이의 제조방법, 및, 이를 함유하는 탈모방지 또는 발모촉진용 조성물 |
| FR3020951B1 (fr) * | 2014-05-16 | 2016-06-17 | Pierre Fabre Dermo Cosmetique | Association d'un tetrapeptide et d'un glyceryl ester pour le traitement de l'alopecie androgenique. |
| ES2882102T3 (es) * | 2015-08-21 | 2021-12-01 | A Novation Cosmetics Gmbh | Combinaciones activas, composiciones y métodos para mejorar el crecimiento del pelo |
| FR3052453B1 (fr) * | 2016-06-14 | 2018-05-18 | Sederma | Peptide, composition le comprenant et utilisations notamment cosmetiques |
| KR101948238B1 (ko) * | 2016-08-19 | 2019-02-14 | (주)케어젠 | 미녹시딜과 펩타이드의 결합체 |
| KR102160566B1 (ko) * | 2019-01-16 | 2020-09-28 | (주)케어젠 | 미녹시딜과 펩타이드의 결합체 |
| KR102697851B1 (ko) * | 2021-07-29 | 2024-08-22 | (주)젠퓨어 | 탈모방지용 화장료 조성물 |
| KR20250057208A (ko) * | 2023-10-19 | 2025-04-29 | 주식회사 바이오빛 | 재조합 폴리펩티드를 포함하는 탈모 방지 또는 발모 촉진용 조성물 |
| FR3158043A1 (fr) * | 2024-01-09 | 2025-07-11 | Lucas Meyer Cosmetics | Combinaison d’actifs cosmétiques pour maintenir ou rééquilibrer le microbiote cutané |
Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS61191694A (ja) * | 1985-02-08 | 1986-08-26 | プロサイト コーポレーション | ＣＨＬ‐Ｃｕの化学的誘導体 |
| JPH06305941A (ja) * | 1993-04-15 | 1994-11-01 | Procyte Corp | 毛の成長を促進する医薬及び化粧品 |
| WO1995023580A1 (en) * | 1994-03-03 | 1995-09-08 | Procyte Corporation | Preventive and remedy for secondary depilation |
| JPH08140628A (ja) * | 1994-11-28 | 1996-06-04 | Meiji Milk Prod Co Ltd | ゲル化食品組成物 |
| JP2000500447A (ja) * | 1995-11-15 | 2000-01-18 | アンスティテュ・ヨーロペアン・ドゥ・ビョロジ・セリュレール | 胸腺ホルモン由来のペプチド複合体、その医薬用途およびそれを含有する組成物 |
| JP2000512613A (ja) * | 1995-11-15 | 2000-09-26 | アンスティテュ・ヨーロペアン・ドゥ・ビョロジ・セリュレール | ペプチド複合体、医薬品としてのその用途およびそれを含有する組成物 |
| WO2000058347A1 (fr) * | 1999-03-30 | 2000-10-05 | Sederma | Compositions cosmetiques ou dermopharmaceutiques contenant le tripeptide n-biotinyl-gly-his-lys, pour prevenir, reduire ou supprimer la chute des cheveux ainsi que pour favoriser leur repousse |
| WO2003030860A1 (en) * | 2001-10-05 | 2003-04-17 | Procyte Corporation | Skin care compositions containing peptide copper complexes and retinol, retinol derivatives, or a mixture thereof |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5120831A (en) * | 1985-02-08 | 1992-06-09 | Procyte Corporation | Metal-peptide compositions |
| US4810693A (en) * | 1985-02-08 | 1989-03-07 | Procyte Corporation | Method for inducing biological coverings in wounds |
| US5470876A (en) * | 1985-07-18 | 1995-11-28 | Proctor; Peter H. | Topical sod for treating hair loss |
| DE3851203T2 (de) * | 1987-05-11 | 1994-12-15 | Procyte Corp | Gebrauch von GHL-Cu Derivaten für die Herstellung eines Medikaments zur Stimulierung des Haarwachstums. |
| EP0293837B1 (en) | 1987-06-01 | 1992-01-15 | Keikichi Sugiyama | Composition for application to hair or scalp |
| DE4127790A1 (de) * | 1991-08-22 | 1993-02-25 | Wank Anna | Verwendung von oligopeptiden mit 2 bis 5 peptidbindungen fuer kosmetische zwecke und einige neue oligopeptid-metallkomplexe |
| FR2733421B1 (fr) | 1995-04-28 | 1997-06-06 | Oreal | Utilisation de derives de l'hormone stimulatrice des melanocytes de type alpha pour stimuler ou induire la pousse des cheveux et/ou stopper leur chute |
| JPH107698A (ja) | 1996-04-24 | 1998-01-13 | Sumitomo Electric Ind Ltd | エピモルフィン・アンタゴニスト |
| JP3903503B2 (ja) | 1996-11-18 | 2007-04-11 | 住友電気工業株式会社 | 可溶性ポリペプチド |
| WO2001098348A2 (en) | 2000-06-22 | 2001-12-27 | Holick Michael F | Regulation of cellproliferation and differentiation using topically applied peptides |
-
2003
- 2003-07-18 FR FR0308801A patent/FR2857597B1/fr not_active Expired - Lifetime
-
2004
- 2004-07-16 ES ES04767703T patent/ES2401686T3/es not_active Expired - Lifetime
- 2004-07-16 WO PCT/FR2004/001879 patent/WO2005009456A2/fr not_active Ceased
- 2004-07-16 CA CA2532679A patent/CA2532679C/fr not_active Expired - Lifetime
- 2004-07-16 US US10/565,007 patent/US7507719B2/en not_active Expired - Lifetime
- 2004-07-16 JP JP2006519970A patent/JP2007516209A/ja active Pending
- 2004-07-16 EP EP04767703A patent/EP1663285B1/fr not_active Expired - Lifetime
-
2012
- 2012-08-10 JP JP2012178403A patent/JP6006582B2/ja not_active Expired - Lifetime
-
2015
- 2015-02-06 JP JP2015022587A patent/JP6149053B2/ja not_active Expired - Lifetime
Patent Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS61191694A (ja) * | 1985-02-08 | 1986-08-26 | プロサイト コーポレーション | ＣＨＬ‐Ｃｕの化学的誘導体 |
| JPH06305941A (ja) * | 1993-04-15 | 1994-11-01 | Procyte Corp | 毛の成長を促進する医薬及び化粧品 |
| WO1995023580A1 (en) * | 1994-03-03 | 1995-09-08 | Procyte Corporation | Preventive and remedy for secondary depilation |
| JPH08140628A (ja) * | 1994-11-28 | 1996-06-04 | Meiji Milk Prod Co Ltd | ゲル化食品組成物 |
| JP2000500447A (ja) * | 1995-11-15 | 2000-01-18 | アンスティテュ・ヨーロペアン・ドゥ・ビョロジ・セリュレール | 胸腺ホルモン由来のペプチド複合体、その医薬用途およびそれを含有する組成物 |
| JP2000512613A (ja) * | 1995-11-15 | 2000-09-26 | アンスティテュ・ヨーロペアン・ドゥ・ビョロジ・セリュレール | ペプチド複合体、医薬品としてのその用途およびそれを含有する組成物 |
| WO2000058347A1 (fr) * | 1999-03-30 | 2000-10-05 | Sederma | Compositions cosmetiques ou dermopharmaceutiques contenant le tripeptide n-biotinyl-gly-his-lys, pour prevenir, reduire ou supprimer la chute des cheveux ainsi que pour favoriser leur repousse |
| WO2003030860A1 (en) * | 2001-10-05 | 2003-04-17 | Procyte Corporation | Skin care compositions containing peptide copper complexes and retinol, retinol derivatives, or a mixture thereof |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2010531815A (ja) * | 2007-06-29 | 2010-09-30 | イノーバクティブ インク． | 新規化合物、化粧品用途および薬用化粧品用途におけるその使用、および該化合物を含む組成物 |
| JP2018532774A (ja) * | 2015-10-09 | 2018-11-08 | アンスティテュ・ヨーロペアン・ドゥ・ビョロジ・セリュレールＩｎｓｔｉｔｕｔ Ｅｕｒｏｐｅｅｎ Ｄｅ Ｂｉｏｌｏｇｉｅ Ｃｅｌｌｕｌａｉｒｅ | 脱毛症の予防的及び根治的治療において使用するペプチド |
Also Published As
| Publication number | Publication date |
|---|---|
| JP2013010769A (ja) | 2013-01-17 |
| CA2532679A1 (fr) | 2005-02-03 |
| FR2857597A1 (fr) | 2005-01-21 |
| JP6149053B2 (ja) | 2017-06-14 |
| CA2532679C (fr) | 2014-05-20 |
| WO2005009456A2 (fr) | 2005-02-03 |
| WO2005009456A3 (fr) | 2005-05-26 |
| FR2857597B1 (fr) | 2008-01-25 |
| JP6006582B2 (ja) | 2016-10-12 |
| EP1663285A2 (fr) | 2006-06-07 |
| JP2015134777A (ja) | 2015-07-27 |
| EP1663285B1 (fr) | 2013-01-16 |
| US7507719B2 (en) | 2009-03-24 |
| ES2401686T3 (es) | 2013-04-23 |
| US20070004633A1 (en) | 2007-01-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6006582B2 (ja) | 脱毛症の予防および治療的処置用組成物の製造のためのペプチド複合体の使用 | |
| JP4729562B2 (ja) | Ｍｓｈのペプチドまたは複合ペプチド誘導体および白毛症の美容治療におけるそれらの使用 | |
| AU2001275018B2 (en) | Composition and method for enhancing elasticity of tissue | |
| JP2000512613A (ja) | ペプチド複合体、医薬品としてのその用途およびそれを含有する組成物 | |
| JP6043283B2 (ja) | セルライト等の皮膚状態を治療するためのｎ−アシルアミノ酸誘導体 | |
| AU2001275018A1 (en) | Composition and method for enhancing elasticity of tissue | |
| JP4656059B2 (ja) | 脱毛症の予防および治療的処置のための新規ペプチド複合体 | |
| JP4273662B2 (ja) | メラノサイト刺激ホルモン阻害剤 | |
| US6809075B1 (en) | Elastin peptide analogs and uses of same incombination with skin enhancing agents | |
| JP2008530181A (ja) | 少なくとも１種類の天然Ａｃ−Ｎ−Ｓｅｒ−Ａｓｐ−Ｌｙｓ−Ｐｒｏテトラペプチドまたはその類似体の１つの、毛髪喪失を遅延させ、かつ／または毛髪成長を刺激するための薬剤としての化粧料的使用 | |
| JPWO2000064926A1 (ja) | メラノサイト刺激ホルモン阻害剤 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20070521 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20091118 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20100601 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20100823 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20100830 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20100928 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20101005 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20101101 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20101109 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20101130 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20110809 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20111108 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20111115 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20111209 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20111216 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20111216 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20120410 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20120810 |
|
| RD04 | Notification of resignation of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7424 Effective date: 20130528 |